|
加巴喷丁相关化合物D市场分析报告
|
Global Market Report of Gabapentin Related Compound E (CAS 67950-95-2) December 2024
DepoMed Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... developed, extended release formulation of the compound gabapentin. The company has entered into ... has conducted a proof-of-concept study related to its DM-3458 program for ... granting Merck a license to certain patents related to its metformin extended release ...
Teva Pharmaceutical Industries Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... (omeprazole), Ventolin (salbutamol sulfate), Neurontin (gabapentin), Eloxatin (oxaliplatin), Casodex (bicalutamide), Rhinocort ... received 1,035 generic approvals in Europe relating to 164 compounds in 324 formulations, including 12 European ...
2020 Cancer Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... growth factor inhibitors; lipoprotein receptor-related protein (LRP-1); Mas receptor ... Pain development Cancer Pain pipeline compounds and molecules under study by both ... saracatinib difumarate, HS198, CA-051, DWP17061, gabapentin, RBM-004, RBM-007, HP-3150 ...
Hormone Replacement Therapy (HRT): Market Research Report This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and ...
Menopausal Hot Flash Market Report: Trends, Forecast and Competitive Analysis to 2031 ... hormonal treatments like SSRIs and gabapentin are increasingly emphasized. These ... expectancy contribute to a higher incidence of menopause-related symptoms. As more women reach ... such as SSRIs, SNRIs, and novel compounds, addresses patient concerns about ...
GABA Receptor Antagonists – Pipeline Insight, 2020 ... receptor antagonists act as subtype-selective compounds and help to study the behavioral ... Mergers and acquisitions, licensing activities related to the GABA Receptor Antagonists therapeutics ... SGS 742 Afizagabar Golexanolone Gabapentin/trazodone hydrochloride
|
|
|